- Home
- PNI vs INCR Comparison
PNI vs INCR Comparison
Compare PNI & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNI
- INCR
- Stock Information
- Founded
- PNI 2002
- INCR 1994
- Country
- PNI United States
- INCR Israel
- Employees
- PNI N/A
- INCR N/A
- Industry
- PNI Trusts Except Educational Religious and Charitable
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- PNI Finance
- INCR Health Care
- Exchange
- PNI Nasdaq
- INCR Nasdaq
- Market Cap
- PNI 75.2M
- INCR 84.5M
- IPO Year
- PNI N/A
- INCR N/A
- Fundamental
- Price
- PNI $6.77
- INCR $1.48
- Analyst Decision
- PNI
- INCR
- Analyst Count
- PNI 0
- INCR 0
- Target Price
- PNI N/A
- INCR N/A
- AVG Volume (30 Days)
- PNI 26.4K
- INCR 16.3K
- Earning Date
- PNI 01-01-0001
- INCR 08-15-2025
- Dividend Yield
- PNI 4.76%
- INCR N/A
- EPS Growth
- PNI N/A
- INCR N/A
- EPS
- PNI N/A
- INCR N/A
- Revenue
- PNI N/A
- INCR $65,575,323.00
- Revenue This Year
- PNI N/A
- INCR $69.54
- Revenue Next Year
- PNI N/A
- INCR $41.75
- P/E Ratio
- PNI N/A
- INCR N/A
- Revenue Growth
- PNI N/A
- INCR N/A
- 52 Week Low
- PNI $6.03
- INCR $1.17
- 52 Week High
- PNI $7.89
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- PNI 57.94
- INCR 45.71
- Support Level
- PNI $6.61
- INCR $1.43
- Resistance Level
- PNI $6.71
- INCR $1.50
- Average True Range (ATR)
- PNI 0.06
- INCR 0.06
- MACD
- PNI 0.01
- INCR -0.00
- Stochastic Oscillator
- PNI 100.00
- INCR 38.46
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.